Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.96 USD | +0.41% | -0.37% | -10.53% |
May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.53% | 4.73B | |
+69.92% | 62.86B | |
-0.95% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.49% | 26.46B | |
-21.81% | 18.9B | |
+4.29% | 12.67B | |
+23.80% | 12.27B | |
+28.99% | 12.07B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Needham Adjusts Price Target on CRISPR Therapeutics to $88 From $90, Keeps Buy Rating